Kyverna Therapeutics, Inc. License Agreements
2 Contracts & Agreements
- Patent License Agreement (License Number L-159-2021-0), dated May 27, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health (Filed With SEC on January 16, 2024)
- Patent License Agreement (License Number L-158-2021-0), dated May 20, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health (Filed With SEC on January 16, 2024)
